Lexeo Therapeutics, Inc. (LXEO) — Dilution Risk Analysis
Current Snapshot
Lexeo Therapeutics, Inc. (LXEO) has a DilutionWatch score of 42/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 42/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: XBRL 1, 8-K 1, 3 1, 4 7.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-4037-xbrl_warrant |
| 8-K | 2026-04-30 | 0001193125-26-193927 |
| 3 | 2026-04-30 | 0001777421-26-000002 |
| 4 | 2026-04-30 | 0001777421-26-000003 |
| 4 | 2026-04-07 | 0001995218-26-000009 |
| 4 | 2026-03-17 | 0002024096-26-000007 |
| 4 | 2026-03-17 | 0001995218-26-000006 |
| 4 | 2026-02-20 | 0001995218-26-000004 |
| 4 | 2026-02-20 | 0002024096-26-000005 |
| 4 | 2026-02-17 | 0002109299-26-000004 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 25 months | Source |
| Three-year share count growth | 207.92% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 42/10) Source
- Cash Runway
- 25 months Source
- Share Count Growth (3-Year)
- 207.92% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.